Insider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 836 Shares of Stock

Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 836 shares of the business's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $50.00, for a total transaction of $41,800.00. Following the transaction, the director now directly owns 278,109 shares in the company, valued at approximately $13,905,450. The trade was a 0.30 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Pro-Dex Trading Up 0.5 %

Shares of Pro-Dex stock traded up $0.25 during trading hours on Friday, hitting $50.90. The company's stock had a trading volume of 37,363 shares, compared to its average volume of 22,955. The stock has a market cap of $165.98 million, a price-to-earnings ratio of 25.32 and a beta of 0.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. Pro-Dex, Inc. has a twelve month low of $16.84 and a twelve month high of $59.60. The firm has a fifty day moving average of $41.10 and a 200-day moving average of $40.76.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last posted its earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. Research analysts forecast that Pro-Dex, Inc. will post 2 EPS for the current year.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Pro-Dex from a "buy" rating to a "hold" rating in a report on Wednesday, March 12th.

Institutional Trading of Pro-Dex

Several institutional investors have recently added to or reduced their stakes in the stock. EAM Investors LLC purchased a new position in shares of Pro-Dex during the fourth quarter worth $1,047,000. O Shaughnessy Asset Management LLC acquired a new position in Pro-Dex during the 4th quarter worth about $995,000. 683 Capital Management LLC purchased a new position in Pro-Dex during the 4th quarter valued at about $739,000. Ritholtz Wealth Management acquired a new position in Pro-Dex in the 4th quarter valued at about $572,000. Finally, American Century Companies Inc. purchased a new stake in Pro-Dex during the fourth quarter worth about $558,000. Institutional investors and hedge funds own 15.28% of the company's stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.